Detalhe da pesquisa
1.
MTN-033: a Phase 1 Study Comparing Applicator versus "as Lubricant" Delivery of Rectal Dapivirine Gel.
Antimicrob Agents Chemother
; 66(11): e0081622, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255254
2.
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
AIDS Behav
; 26(5): 1333-1346, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657218
3.
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.
AAPS PharmSciTech
; 22(3): 83, 2021 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625602
4.
Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.
Arch Sex Behav
; 46(4): 1111-1119, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27571742
5.
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
AIDS Res Hum Retroviruses
; 38(4): 257-268, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498980
6.
Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).
AIDS Educ Prev
; 33(5): 361-376, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596427
7.
Assessing the potential of the Woman's Condom for vaginal drug delivery.
Contraception
; 92(3): 254-60, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25998936